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Background: Identifying a neural circuit mechanism that is differentially involved in tremor would aid in the
diagnosis and cure of such cases. Here, we demonstrate that tremor-related cortical potential (TRCP) is differentially
expressed in two different mouse models of tremor.
Results: Hybrid tremor analysis of harmaline-induced and genetic tremor in mice revealed that two authentic
tremor frequencies for each type of tremor were conserved and showed an opposite dependence on CaV3.1 T-type
Ca2+ channels. Electroencephalogram recordings revealed that α1−/−;α1G-/- mice double-null for the GABA receptor
α1 subunit (Gabra1) and CaV3.1 T-type Ca2+ channels (Cacna1g), in which the tremor caused by the absence of
Gabra1 is potentiated by the absence of Cacna1g, showed a coherent TRCP that exhibited an onset that preceded
the initiation of behavioral tremor by 3 ms. However, harmaline-induced tremor, which is known to be abolished
by α1G−/−, showed no TRCP.
Conclusions: Our results demonstrate that the α1−/−;α1G−/− double-knockout tremor model is useful for studying
cortical mechanisms of tremor.
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Tremor is an involuntary rhythmic oscillation of body parts
[1,2]. Various mechanism ranges from reflex loop to central
oscillation has been proposed for the origin of oscillatory
activity generating tremor [1,2]. Animal models of tremor
have been contributed to examine those hypotheses.
Harmaline is a plant-derived metabolite used to induce
tremor in animals [3-5]. Harmaline tremor is an action-
induced tremor and coherent with pathological oscillation
in olivocerebellar pathway, which propagates to reticu-
lospinal pathway and entrains muscles with synchronized
oscillation [4,6,7]. Either knockout of the Cacna1g gene
encoding the CaV3.1 channel α1G subunit (α1G
−/− mice)
or pharmacological blockage of T-type Ca2+ channels in
the inferior olive abolishes 10–15 Hz harmaline-induced
tremor and the pathological oscillation [8], suggesting that* Correspondence: daesoo@kaist.ac.kr
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harmaline tremor.
T-type calcium channel has a contradictory role in the
other model of action-induced tremor. In Gabra1 model
of action tremor, knockout mice of α1 subunit of the γ-
aminobutyric acid (GABA) receptor, additional knockout
of α1G enhances action-induced tremor [9]. Considering
that T-type calcium channel is involved in thalamocortical
oscillations [10,11] and cortical lesion has no effect on
harmaline tremor [7,12], we hypothesized that two tremor
models has different involvement of cortical mechanisms.
Here, using pharmacogenetic dissection of tremor fre-
quencizes and high-resolution electroencephalograzphic
(EEG) techniques [13] combining with event-related
potential analysis(ERP) [14-17], we reveal that abnormal
cortical rhythmicity in the form of tremor-related cortical
potential (TRCP) is differentially expressed between har-
maline and genetic models of action tremor.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Pharmacogenetic determination of tremor frequency
independence
To test the independence of mechanism between harma-
line and genetic tremors (α1−/− and α1−/−;α1G−/−) [9], we
performed pharmacogenetic experiment in which two
types of tremor were produced in a mouse. We predicted
two possibilities. The first is that the two tremor mecha-
nisms interact to generate a hybrid tremor according to
the dominant/recessive relationship between them. Alter-
natively, the two tremor frequencies may emerge inde-
pendently, like the difference in behavior between two
genes on separate chromosomes.
After harmaline administration (9 mg/kg), wild-type
(WT) mice exhibited only 10–15 Hz tremor (Figure 1A-C,
left), whereas α1−/−;α1G−/− mice showed only 15–30 HzFigure 1 Functionally distinct tremorogenesis in harmaline tremor an
injection into WT (left), α1−/− (center), and α1−/−;α1G−/− (right) mice (n = 3 p
and power spectral analysis (C). (D) Comparison of tremor frequencies in Wtremor (Figure 1A-C, right). In contrast, harmaline-
treated α1−/− mice exhibited two separable band frequen-
cies, 10–15 and 15–30 Hz, reflecting the coexistence of
authentic harmaline and genetic tremor (Figure 1A-C,
middle, and Figure 1D). Considering that the different
tremor frequencies reflect the involvement of different
neural circuit mechanisms [1,2], the two action tremor
models appear to have distinct neural circuit mechanisms.
Tremor-related cortical potentials in α1−/−;α1G−/− mice
Using high-resolution EEG covering the whole frontal and
occipital cortex (Figure 2A) and forelimb electromyog-
raphy (EMG), we measured the cortical activity associated
with forelimb tremor in α1−/−;α1G−/− mice. We isolated
cortical potentials associated with tremor onset by aver-
aging EEG activity corresponding to the first discharge ofd α1-/-;α1G−/− tremor. (A-C) Tremor after harmaline (15 mg/kg)
er genotype) are shown as accelerometer signal (A), spectrogram (B),
T (left), α1−/− (center), and α1−/−;α1G−/− mice. T-test, *P < 0.05.
Figure 2 Tremor onset-related cortical potential in α1−/−;α1G−/− mice. (A) Schematic diagram of EEG, EMG, and accelerometer recordings
during mouse behavior. EMG activity was recorded from triceps brachii of left and right forelimbs. Topography of the high-resolution EEG array
attached to the skull (middle) and locations of channels (right). The topography of the high-resolution EEG array was adapted with permission
from Lee et al. (2011) [18]. (B) Representative EEG, EMG, and accelerometer (Acc.) traces upon α1-/-;α1G−/− tremor onset. The EMG shown is from
the right forelimb. (C) ERPs of tremor onset. Different colored traces indicate averaged activity of different channels. (D) Spectrogram (top),
inter-trial coherence (bottom), and (E) 15–30 Hz power of ERPs from the left S1 (n = 3) during tremor onset. Ol, olfactory cortex; FrA, frontal
association cortex; M2, secondary motor cortex; M1, primary motor cortex; S1, primary somatosensory cortex; V2, secondary visual cortex; V1,
primary visual cortex; Cb, cerebellar cortex.
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α1−/−;α1G−/− mice initiated approximately 3 ms prior to
behavioral tremor onset and were followed by 15–30 Hz
oscillations corresponding to the accompanying muscular
tremor discharges (Figure 2B and C). The resulting TRCPs
were phase-locked to the 15–30 Hz tremor (Figure 2B
and C), although their amplitudes and phases were vari-
able among channels (Figure 2B and C), indicating the
differential involvement of cortical subdomains. Power
spectral analyses also confirmed that TRCPs were initi-
ated upon tremor onset (Figure 2D, upper, and 2E) and
coincided with tremor events (Figure 2D, lower). These
results indicate that the α1-/-;α1G−/− tremor includes
the cortical circuit mechanism, although the origin re-
mains unknown.
No TRCPs in harmaline tremor
We then compared TRCPs in the two tremor models.
When we aligned and averaged EEG traces along thetiming of tremor discharges in α1-/-;α1G−/− mice, TRCPs
were obtained as an oscillatory pattern (Figure 3A, left).
However, TRCPs were not found in harmaline tremor
(Figure 3A, right) or in non-tremor contractions of
α1−/−;α1G−/− mice (Figure 3A, middle). The power and
coherence of TRCPs were significantly lower in harma-
line tremor than in α1−/−;α1G−/− tremor (Figure 3B-D).
These results suggest that TRCPs can be a robust meas-
ure for discriminating these two types of tremor models.
Discussion
Essential tremor is a neurological condition character-
ized by action-induced tremors [2,19]. Considerable evi-
dence suggests that essential tremor is heterogeneous
with respect to affected body parts, tremor frequency,
and drug sensitivity [20-24]. The heterogeneity appears
to reflect the involvement of different neural substrates.
While some studies have reported that abnormal cortical
rhythms are associated with tremor in a subset of essential
Figure 3 Comparison of tremor-related activity between two essential tremor models. (A) ERPs (top) and right forelimb (RF) EMG activity
(bottom) upon α1−/−;α1G−/− tremor discharge (left), α1−/−;α1G−/− non-tremor discharge (center), and harmaline tremor discharge (right). Arrows
indicate each tremor discharge. Spectrogram (B) and inter-trial coherence (C) for the EEG channel on the left S1. For A to C, 100 events were
randomly chosen from among all events for comparisons between ERPs. (D) 10–30 Hz power (left) and inter-trial coherence (right) for the EEG
channel on the left S1 (n = 3 for each). Asterisks indicate comparisons between α1−/−;α1G−/− tremor and harmaline tremor (light blue), and
between tremor and non-tremor in α1-/-;α1G−/− mice (gray). *P < 0.05 (two-tailed t-test).
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find such a correlation [27], necessitating in-depth com-
parative studies on cortical involvement in the generation
of essential tremor [25-28].
Two action-induced tremor models used in present
study has been proposed as an animal models of essen-
tial tremor [4,9]. By employing event-related potential
analysis, we identified TRCPs in α1-/-;α1G-/- mice. How-
ever, we failed to find out tremor-related activity in har-
maline tremor, suggesting that two models of tremor
have different cortical dependency.Whereas harmaline and α1−/− tremors are ameliorated
by propranolol [29,30], α1−/−;α1G−/− tremor is resistant
to propranolol [9]. Deuschl et al. reported that the pa-
tients with propranolol susceptibility show synchronous
activity between agonist and antagonist muscles during
tremor, whereas the patients with propranolol resistance
exhibit reciprocal antagonist muscle activity [20]. Not-
ably, harmaline tremor, which is sensitive to propranolol
[30], also shows co-contraction of agonist and antagonist
muscle pairs during tremor [31]. Thus, it is plausible that
the TRCP serves a role in generating propranolol-resistant
Park et al. Molecular Brain  (2015) 8:3 Page 5 of 7or reciprocal agonist–antagonist contracting subtypes of
essential tremor. A comparative study on the cortical ac-
tivity of essential tremor patients with different pheno-
types would effectively test this hypothesis.
The two essential tremor models in this study are also
different with respect to their underlying neural circuit
mechanism. The CaV3.1 channel is expressed in various
motor pathways and may serve different functions [32].
In the thalamocortical pathway, where both Gabra1 and
CaV3.1 genes are co-expressed [33], CaV3.1 may play an
inhibitory role in tremorogenesis. In contrast, CaV3.1 is
involved in the generation of tremor in the inferior olive
nucleus [8,32]. Inferior olive neurons are connected to
muscles through the cerebelloreticulospinal pathway
[6,34]. This means that harmaline could induce tremor
while bypassing the involvement of the thalamocortical
pathway. Indeed, evidence shows that neither the thal-
amus nor the motor cortex is associated with harmaline-
induced tremor [7,12].
The TRCP in α1-/-;α1G-/- mice is not merely a sensory
feedback or a movement artifact for a number of rea-
sons. First, it occurred prior to the onset of tremor, at
least in some channels, suggesting the possibility that
TRCPs are involved in the mechanism responsible for
tremor onset (Figure 2). Moreover, TRCPs were not ob-
served in harmaline tremor, which have an intensity simi-
lar to that of α1−/−;α1G−/− tremor (Figure 3). Although
tremoring muscle is known to provide sensory feedback to
the cortex, it is not likely that our method is sensitive
enough to detect the low level of associated neural activity.
These TRCP findings suggest that the two types of tremor
are differentially associated with physiological and neural
circuit mechanisms.
In conclusion, we have demonstrated the presence of
TRCP only in a certain animal model of essential tremor,
suggesting its mechanistic heterogeneity. The TRCP char-
acterized in our study could be a useful readout for the
diagnosis of essential tremor type. Notably, in patients
showing a high level of TRCP, therapeutic strategies that
target thalamocortical pathways, rather than T-type Ca2+
channel blockers, might be effective. Furthermore, the
α1−/−;α1G−/− mouse should be a useful model for re-
vealing how the cerebral cortex can generate tremor.
Methods
Animals
Animal care and handling conformed to the institutional
guidelines of the Animal Care and Use Committee of
the Korea Advanced Institute of Science and Technology
(KAIST). Mice heterozygous for GABAA receptor α1 de-
letion (α1+/−) in a C57BL/6 J genetic background were
obtained from Dr. Gregg E. Homanics at the University
of Pittsburgh. Crossing α1+/− and α1G+/− mice yielded
double-heterozygous animals (α1+/−;α1G+/−), which weremated to produce WT (α1+/+;α1G+/+), α1 mutant
(α1−/−;α1G+/+), and double-mutant (α1−/−;α1G−/−) mice.
WT mice were utilized for the harmaline-induced
tremor model. All experiments were performed using
adult mice (>10 weeks old). Mice were housed under a
12-hour light/dark cycle (7 a.m. to 7 p.m.) with free ac-
cess to water and food.High-resolution EEG
EEG electrode arrays were prepared as previously de-
scribed [13]. For surgical anesthesia, ketamine (100 mg/
kg) mixed with xylazine (5 mg/kg) was administered in-
traperitoneally. After surgical anesthesia had developed,
the head of the mouse was fixed on a stereotaxic appar-
atus (David Kopf Instruments, CA, USA), and an inci-
sion of ~2.5 cm was made on the scalp. The skull was
exposed using micro-clamps, and tissue debris was re-
moved by carefully wiping with a 70% ethanol-soaked
cotton ball. After moisturizing the skull surface with a
drop of tap water, a polyamide-based, high-density film
electrode was placed on the skull and carefully posi-
tioned so that the vertical midline was aligned with the
skull midline and the bregma met the upper edge of the
third branch. After positioning the electrode, two screws
were implanted onto the skull, and dental acrylate was
coated over the electrode array. The viscosity of the dental
acrylate mix used was carefully examined before applica-
tion. Mice were allowed to recover under an infrared lamp
and housed singly until the experiment.Electromyography
The electrodes for electromyography (EMG) in mice
were made with Teflon-coated stainless steel wires (A-M
Systems, WA, USA) and implanted as previously de-
scribed [35]. Briefly, two wires were combined and twisted
together with a knot 4 cm from the end. The Teflon
insulation was removed from 0.5-mm-long segments 1 or
2 mm from the knot in both wires to create two exposures
located 1 mm apart. The ends of both wires were crum-
pled into the shaft of a 26-gauge needle. The opposite
ends of the wires were cut ~8 cm from the knot, bared,
and soldered to a connector. After the fur in the dorsal
neck region was shaved away, small incisions were made
in the skin above the left and right forelimb muscles (tri-
ceps brachii). EMG electrodes were inserted under the
skin from the neck incision to the muscles. The needle
harboring the electrode was inserted into the target
muscle until the knot proximal to the bared regions was
firmly butted against the surface of the muscle. The distal
end of the electrode exiting the muscle was loosely knot-
ted, and the knot was moved to the muscle surface and
tightened. Incisions in the limbs were closed with silk su-
turing material.
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After habituation in the recording room for 30 minutes,
the mouse was placed on a stainless steel plate (25 cm
diameter) suspended by two elastic rubber bands. The
edge of the plate was surrounded by paper (5 cm wide)
to prevent mice from falling off. The behavior of the
mouse was monitored using a video camera positioned
above the platform. For induction of harmaline tremor,
harmaline hydrochloride dissolved in 0.9% saline was
injected intraperitoneally (15 mg/kg). A DC response
accelerometer (Model No. 3711D1FA3G; Piezotronics,
NY, USA) was mounted below the steel plate to aid in
tremor detection.
Acquisition of EEG and EMG signals
High-resolution EEG, EMG, and accelerometer signals
were obtained using a SynAmps2 amplifier (Neuroscan
Inc., TX, USA) with a 2000-Hz sampling rate. Channel
34 of the EEG was used as a reference and channel 33
was used as a ground. Contact impedances of EEG chan-
nels were measured using Scan 4.3 software (Neuroscan
Inc.) with 30-Hz test pulses. EEG channels with abnor-
mal impedance (>500 kOhm) were excluded from fur-
ther analyses.
Analysis of tremor-related potentials
Pre-processing
All signal processing and analyses were performed using
the Matlab-based open source toolbox EEGLAB [36] or
custom Matlab codes. Signals were loaded onto EEGLAB
and filtered with a 100–Hz high-pass filter for EMG signals
and a 1–200 Hz band-pass filter for EEG and accelerom-
eter signals. All filters used were finite-impulse response
filters. EEG signals were re-referenced by common average
reference using an EEGLAB plug-in algorithm.
Tremor detection
EMG traces obtained from the left or right forelimb tri-
ceps brachii muscle were used for measuring tremor. Raw
EMG traces were rectified and smoothed using a moving-
average window. A cluster of EMG action potentials with
peak amplitudes 2.5-fold greater than the standard devi-
ation of baseline EMG activity and separated from others
by more than 25 ms was defined as an ‘EMG discharge’.
Rhythmic and successive EMG discharges in a specific fre-
quency range (15–30 Hz for α1−/−;α1G−/− and 10–15 Hz
for harmaline tremor) were identified as a ‘tremor epoch’.
Each EMG discharge in a tremor epoch was defined as a
‘tremor discharge’. The ‘tremor onset’ was determined
as the onset time of the first tremor discharge in a
tremor epoch. Irregular EMG discharges temporally
separated from the tremor epoch by more than 1 second
in α1−/−;α1G−/− mice were identified as ‘non-tremor dis-
charges’. Tremor onset is used for ERP analysis inFigure 2. However, we used tremor discharge itself for
comparing TRCP in two tremor models (Figure 3) be-
cause single tremor epoch is much longer in harmaline
tremor so that it was hard to collect enough number of
tremor epochs for ERP analysis. Event detection was per-
formed in the left and right forelimb independently using
Matlab codes, and was confirmed by visual inspection.
Event-related potential analysis
EEG channel activity during each event (500 ms pre-
and post-event) was collected, and a baseline correction
was applied to the pre-event period for each event and
channel. For the calculation of ERPs, the waveforms of
collected events (>100 for tremor discharge and non-
tremor discharge, and >50 for tremor onset) were aver-
aged, and the ERP from each channel was plotted in a
different color. ERPs of tremor onset, tremor discharge
and non-tremor discharge for α1−/−;α1G−/− and harma-
line tremor models were calculated, and ERPs of tremor
onset and tremor discharge were identified as TRCPs.
Tremor events that occurred in only one forelimb at a
given moment (>0.5 seconds apart from contralateral
limb tremor events) were used for ERP calculations. Inter-
trial coherence is a frequency-domain measure of activity
synchronization between event-related trials [36]. Inter-
trial coherence value indicates degree of consistency of
oscillatory phase across trials at certain latency and fre-
quencym [37] and calculated by EEGLab [36].
Statistical analysis
All data are presented as mean values ± SEM, and differ-
ences between experimental groups were analyzed for
statistical significance using Sigmastat 3.1.
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